Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations
Status:
Completed
Trial end date:
2018-06-07
Target enrollment:
Participant gender:
Summary
This is a study of EMB-001 (a combination of two FDA-approved drugs, metyrapone and oxazepam)
in healthy adults.This is a Phase 1, single dose, 3-period, 3-sequence, crossover study in 9
healthy male and female (not of childbearing potential) volunteers. The study will evaluate
the bioavailability and food effect of a new formulation of EMB-001 relative to the original
formulation of EMB 001.
During the study, a total of 9 eligible subjects will be randomized in a 1:1:1 ratio to each
of 3 treatment sequences